Liver Fibrosis, FibroTest‑ActiTest Panel
Use
The FibroTest‑ActiTest Panel provides a non‑invasive evaluation of liver fibrosis (FibroTest) and inflammation (ActiTest), commonly used in patients with chronic hepatitis B or C, NAFLD, or other liver conditions to assess disease severity without requiring biopsy. FibroTest and ActiTest scores correlate to the Metavir staging system, facilitating treatment decisions and monitoring progression.
Special Instructions
Not provided.
Limitations
Not provided.
Methodology
Immunoassay (Nephelometry)
Biomarkers
Result Turnaround Time
5-6 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
3.5 mL
Minimum Volume
2 mL
Collection Instructions
Serum should be separated from the cells as soon as possible after visible clot formation (usually 15‑30 minutes after collection). Avoid freezing and thawing. Overnight fasting is preferred.
Patient Preparation
Overnight fasting is preferred
Causes for Rejection
Gross hemolysis • Grossly lipemic • Patients <2 years old • QNS for one or more analytes
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 24 hours |
| Refrigerated | 72 hours |
| Frozen | −20 °C: 5 days; −70 °C: 28 days |